An update to monoclonal antibody as therapeutic option against COVID-19

With the number of Coronavirus Disease 2019 (COVID-19) cases soaring worldwide and limited vaccine availability for the general population in most countries, the monoclonal antibody (mAb) remains a viable therapeutic option to treat COVID-19 disease and its complications, especially in the elderly i...

Descripción completa

Detalles Bibliográficos
Autores principales: Deb, Paroma, Molla, Md. Maruf Ahmed, Saif-Ur-Rahman, K.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Medical Association Publishing House. Published by Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872849/
https://www.ncbi.nlm.nih.gov/pubmed/33585808
http://dx.doi.org/10.1016/j.bsheal.2021.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872849/
https://www.ncbi.nlm.nih.gov/pubmed/33585808
http://dx.doi.org/10.1016/j.bsheal.2021.02.001

Ejemplares similares